The deal is the latest example of a big pharma company turning to the deal table to bolster its pipeline of autoimmune drugs.
Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion
The deal is the latest example of a big pharma company turning to the deal table to bolster its pipeline of autoimmune drugs.
